Product NDC: | 0179-0018 |
Proprietary Name: | LIOTHYRONINE SODIUM |
Non Proprietary Name: | LIOTHYRONINE SODIUM |
Active Ingredient(s): | 25 ug/1 & nbsp; LIOTHYRONINE SODIUM |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0179-0018 |
Labeler Name: | KAISER FOUNDATION HOSPITALS |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA090097 |
Marketing Category: | ANDA |
Start Marketing Date: | 20090829 |
Package NDC: | 0179-0018-70 |
Package Description: | 30 TABLET in 1 BOX, UNIT-DOSE (0179-0018-70) |
NDC Code | 0179-0018-70 |
Proprietary Name | LIOTHYRONINE SODIUM |
Package Description | 30 TABLET in 1 BOX, UNIT-DOSE (0179-0018-70) |
Product NDC | 0179-0018 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | LIOTHYRONINE SODIUM |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20090829 |
Marketing Category Name | ANDA |
Labeler Name | KAISER FOUNDATION HOSPITALS |
Substance Name | LIOTHYRONINE SODIUM |
Strength Number | 25 |
Strength Unit | ug/1 |
Pharmaceutical Classes | l-Triiodothyronine [EPC],Triiodothyronine [Chemical/Ingredient] |